Cutler Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Cutler Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500	Closed	-$29K	–	5038
2019 Q4	$29K	Buy	+500	New	+$18.8K	﹤0.01%	1996

Cutler Group's BOLD Position: Q1 2020 in Review

Cutler Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 500 shares — an estimated $29K sold.

Cutler Group first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $29K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Cutler Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Cutler Group sold 500 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $29K.
Cutler Group first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Cutler Group's Audentes Therapeutics, Inc position peaked at $29K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.